Management of the nephrotic syndrome.
D000293:Adolescent; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002699:Chlorambucil / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D004341:Drug Evaluation; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007223:Infant; D007246:Infertility / Q000139:chemically induced; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D010919:Placebos; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D011446:Prospective Studies; D011507:Proteinuria / Q000188:drug therapy
D007166:Immunosuppressive Agents; D010919:Placebos; D002699:Chlorambucil; D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone